Literature DB >> 35107679

Moyamoya Disease-Standards and Advances in Revascularization Procedure and Peri-operative Management.

Miki Fujimura1.   

Abstract

Moyamoya disease (MMD) is a chronic, occlusive cerebrovascular disease with unknown etiology characterized by progressive stenosis at the terminal portion of the internal carotid artery and the abnormal vascular network formation at the base of the brain. Superficial temporal artery-middle cerebral artery (STA-MCA) bypass is a preferred surgical procedure for ischemic-onset MMD patients by improving cerebral blood flow. Recent evidence further indicates that flow-augmentation bypass has a potential role for preventing re-bleeding in hemorrhagic-onset MMD patients. Based on such cumulative evidence, there is a worldwide increase in the number of MMD patients undergoing bypass surgery, thus thorough understanding of the basic pathology of MMD including peri-operative hemodynamics is critical for avoiding surgical complications. The author sought to demonstrate the standard surgical procedure of STA-MCA bypass with indirect pial synangiosis for adult MMD patients and its pitfall in the early postoperative period, introducing the characteristic peri-operative hemodynamic condition of adult MMD after surgery, such as local cerebral hyperperfusion and intrinsic hemodynamic ischemia caused by watershed shift phenomenon.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cerebral hyperperfusion; Flow-augmentation bypass; Moyamoya disease; Revascularization surgery; Surgical complication

Mesh:

Year:  2022        PMID: 35107679     DOI: 10.1007/978-3-030-87649-4_9

Source DB:  PubMed          Journal:  Adv Tech Stand Neurosurg        ISSN: 0095-4829


  3 in total

1.  Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial.

Authors:  Takeshi Funaki; Jun C Takahashi; Kiyohiro Houkin; Satoshi Kuroda; Miki Fujimura; Yasutake Tomata; Susumu Miyamoto
Journal:  J Neurosurg       Date:  2019-02-08       Impact factor: 5.115

2.  Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan Adult Moyamoya Trial.

Authors:  Miki Fujimura; Takeshi Funaki; Kiyohiro Houkin; Jun C Takahashi; Satoshi Kuroda; Yasutake Tomata; Teiji Tominaga; Susumu Miyamoto
Journal:  J Neurosurg       Date:  2018-05-04       Impact factor: 5.115

3.  Postoperative Intracerebral Hemorrhage After Combined Revascularization Surgery in Moyamoya Disease: Profiles and Clinical Associations.

Authors:  Kikutaro Tokairin; Ken Kazumata; Haruto Uchino; Masaki Ito; Kota Ono; Ryota Tatezawa; Takafumi Shindo; Masahito Kawabori; Naoki Nakayama; Kiyohiro Houkin
Journal:  World Neurosurg       Date:  2018-08-27       Impact factor: 2.104

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.